Neuraville
Neuraville Overview: Neuraville is advancing artificial general intelligence (AGI) with patented technology and open-source innovation. Our flagship product, Neurorobotics Studio, is built on the open-source FEAGI platform and simplifies the development of advanced control systems for robots. By combining the strengths of open-source with proprietary advancements, Neuraville enables rapid innovation, reduces development costs, and scales across industries. Product: Neurorobotics Studio offers a no-code interface for AI model development, allowing users to create both simple and sophisticated AI models. The platform integrates seamlessly with robotic hardware, simulated environments, and video games, enabling users to train AI models interactively. Whether users have access to physical hardware or not, Neuraville’s platform enables rapid AI experimentation and development. Market Impact: Neuraville is leading the charge in neuromorphic technology, addressing key market demands in areas where adaptability, safety, and efficiency are critical. Our technology is ideally suited for service and field robotics, where real-time adaptability and safety are paramount. Additionally, Neuraville’s platform plays a pivotal role in wearable medical devices, brain-computer interfaces (BCI), and the Internet of Things (IoT), where power efficiency and on-device pattern recognition significantly enhance functionality. By enabling intelligent, energy-efficient, and adaptable systems, Neuraville is unlocking new opportunities across high-growth industries. Investment Highlights: * Scalability: Neurorobotics Studio is a cloud-based solution built for high scalability, enabling seamless growth and global expansion. While currently available to US-based customers, plans are in place to offer the solution internationally. * Proprietary Edge: Patented technologies and proprietary features differentiate Neuraville’s offering, ensuring a competitive advantage in the AI and robotics sectors. * Broad Applications: Neuraville’s platform is applicable across multiple sectors, including service robotics, wearable medical devices, BCI, and IoT, creating diverse revenue streams. * Subscription-Based Model: The platform operates on a subscription-based model, ensuring a predictable and recurring revenue structure as adoption scales. * Strategic Partnerships: The open-source foundation attracts collaborations with leading research institutions, industrial partners, and academic bodies, driving continuous innovation. * Monetization: In addition to subscriptions, monetization channels include enterprise licensing, custom solutions, and premium features, providing multiple avenues for growth. Conclusion: Neuraville is at the forefront of AGI and robotics, positioning itself as a leader in driving innovation across industries. With a blend of open-source and proprietary technology, we are enabling the creation of intelligent systems that are adaptable, scalable, and affordable. Investors have the opportunity to join us in revolutionizing robotics and AI, with a company poised for exponential growth.
Neuraville Overview: Neuraville is advancing artificial general intelligence (AGI) with patented technology and open-source innovation. Our flagship product, Neurorobotics Studio, is built on the open-source FEAGI platform and simplifies the development of advanced control systems for robots. By combining the strengths of open-source with proprietary advancements, Neuraville enables rapid innovation, reduces development costs, and scales across industries. Product: Neurorobotics Studio offers a no-code interface for AI model development, allowing users to create both simple and sophisticated AI models. The platform integrates seamlessly with robotic hardware, simulated environments, and video games, enabling users to train AI models interactively. Whether users have access to physical hardware or not, Neuraville’s platform enables rapid AI experimentation and development. Market Impact: Neuraville is leading the charge in neuromorphic technology, addressing key market demands in areas where adaptability, safety, and efficiency are critical. Our technology is ideally suited for service and field robotics, where real-time adaptability and safety are paramount. Additionally, Neuraville’s platform plays a pivotal role in wearable medical devices, brain-computer interfaces (BCI), and the Internet of Things (IoT), where power efficiency and on-device pattern recognition significantly enhance functionality. By enabling intelligent, energy-efficient, and adaptable systems, Neuraville is unlocking new opportunities across high-growth industries. Investment Highlights: * Scalability: Neurorobotics Studio is a cloud-based solution built for high scalability, enabling seamless growth and global expansion. While currently available to US-based customers, plans are in place to offer the solution internationally. * Proprietary Edge: Patented technologies and proprietary features differentiate Neuraville’s offering, ensuring a competitive advantage in the AI and robotics sectors. * Broad Applications: Neuraville’s platform is applicable across multiple sectors, including service robotics, wearable medical devices, BCI, and IoT, creating diverse revenue streams. * Subscription-Based Model: The platform operates on a subscription-based model, ensuring a predictable and recurring revenue structure as adoption scales. * Strategic Partnerships: The open-source foundation attracts collaborations with leading research institutions, industrial partners, and academic bodies, driving continuous innovation. * Monetization: In addition to subscriptions, monetization channels include enterprise licensing, custom solutions, and premium features, providing multiple avenues for growth. Conclusion: Neuraville is at the forefront of AGI and robotics, positioning itself as a leader in driving innovation across industries. With a blend of open-source and proprietary technology, we are enabling the creation of intelligent systems that are adaptable, scalable, and affordable. Investors have the opportunity to join us in revolutionizing robotics and AI, with a company poised for exponential growth.
Neuraville has raised $140k across 1 round. Its most recent round was a Pre-Seed of $140k in May 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Neuraville is featured in
Similar companies
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Global Sales Tax Compliance Software
Derya is an AI-native freight-forwarding/logistics software company that provides an AI workbench for freight forwarders and related content.
TIFIN is a platform that conceives, creates, and operates fintech companies in the areas of wealth management, investments, and personal finance. Their operating companies are shaping the future of investor experience with intelligent products that recognize the uniqueness of each investor. TIFIN leverages the combined power of investment intelligence, data science, and technology to make investing a more powerful driver of financial well-being.
8090 Solutions provides an AI-native software development platform through Software Factory, a system designed to help teams manage the software development lifecycle from planning to deployment. The platform connects business requirements, architecture planning, implementation tasks, testing, and feedback within a shared workspace using AI-driven workflows and knowledge management. 8090 Solutions enables organizations to coordinate product, engineering, and business teams while maintaining visibility across software projects. The company’s solutions support custom software development, AI-assisted engineering processes, and enterprise software delivery through structured collaboration between teams and AI agents.
Developers no longer have to manually piece together the impact of pull requests; Baz models, analyzes and reviews code changes, detecting breaking changes, enforcing consistency, and highlighting misaligned coding patterns. Baz makes every review faster, more accurate, and aligned with the real-world impact of the code changes being made.
Eccentric Machines is a manufacturer of robotic actuator technology enabling advanced motion control for embodied AI systems.
EIS Automation provides modular automation and robotic solutions for manufacturing.
Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offline recording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.
Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.
Engine Biosciences is a biotech company that uses machine learning to study genomics for the purpose of drug discovery. They are a technology company based in both San Francisco and Asia that is funded by investors. They specialize in network biomedicine and have developed their own patented technologies that involve extensive laboratory experimentation and artificial intelligence algorithms. These technologies are used for both drug discovery and cellular reprogramming. The company's research and development platform, which was created by a team of esteemed scientists and professors from universities such as MIT and Harvard, significantly speeds up and reduces the cost of developing new medical treatments. Engine Biosciences actively utilizes this platform internally and collaborates with partners in various disease areas.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.